Capital World Investors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.87B Buy
11,749,361
+2,056,477
+21% +$479M 0.39% 69
2025
Q4
$2.01B Buy
+9,692,884
New +$1.92B 0.27% 89
2023
Q4
Sell
-2,299,207
Closed -$358M 519
2023
Q3
$358M Sell
2,299,207
-3,721,326
-62% -$614M 0.07% 227
2023
Q2
$996M Sell
6,020,533
-1,093,777
-15% -$177M 0.19% 124
2023
Q1
$1.1B Sell
7,114,310
-2,696,392
-27% -$435M 0.23% 115
2022
Q4
$1.73B Sell
9,810,702
-662,246
-6% -$114M 0.37% 72
2022
Q3
$1.71B Buy
10,472,948
+209,370
+2% +$35.4M 0.38% 62
2022
Q2
$1.82B Buy
10,263,578
+602,349
+6% +$107M 0.39% 64
2022
Q1
$1.71B Sell
9,661,229
-633,717
-6% -$108M 0.29% 87
2021
Q4
$1.76B Buy
10,294,946
+11,485
+0.1% +$1.88M 0.28% 84
2021
Q3
$1.66B Sell
10,283,461
-1,444,940
-12% -$247M 0.28% 89
2021
Q2
$1.93B Sell
11,728,401
-190,487
-2% -$31.5M 0.33% 80
2021
Q1
$1.96B Sell
11,918,888
-11,478,094
-49% -$1.86B 0.36% 73
2020
Q4
$3.68B Buy
23,396,982
+123,303
+0.5% +$18.2M 0.71% 30
2020
Q3
$3.46B Buy
23,273,679
+160,705
+0.7% +$23.8M 0.76% 28
2020
Q2
$3.25B Buy
23,112,974
+1,916,985
+9% +$279M 0.79% 29
2020
Q1
$2.78B Buy
21,195,989
+13,703,905
+183% +$1.94B 0.81% 32
2019
Q4
$1.09B Sell
7,492,084
-9,336,225
-55% -$1.27B 0.24% 104
2019
Q3
$2.18B Buy
16,828,309
+908,389
+6% +$120M 0.52% 53
2019
Q2
$2.22B Buy
15,919,920
+2,585,542
+19% +$358M 0.52% 49
2019
Q1
$1.86B Buy
13,334,378
+1,338,727
+11% +$179M 0.45% 62
2018
Q4
$1.55B Buy
11,995,651
+1,697,500
+16% +$237M 0.42% 63
2018
Q3
$1.42B Sell
10,298,151
-16,656,063
-62% -$2.21B 0.35% 79
2018
Q2
$3.27B Buy
26,954,214
+300,312
+1% +$37.5M 0.7% 37
2018
Q1
$3.42B Buy
26,653,902
+643,896
+2% +$87M 0.77% 31
2017
Q4
$3.63B Sell
26,010,006
-1
-0% -$139 0.79% 32
2017
Q3
$3.38B Sell
26,010,007
-500,000
-2% -$66.3M 0.77% 34
2017
Q2
$3.51B Buy
26,510,007
+1,050,000
+4% +$134M 0.82% 27
2017
Q1
$3.17B Buy
25,460,007
+1,000,000
+4% +$119M 0.76% 32
2016
Q4
$2.82B Buy
24,460,007
+1,000,000
+4% +$116M 0.71% 38
2016
Q3
$2.77B Buy
23,460,007
+1,434,684
+7% +$174M 0.72% 35
2016
Q2
$2.67B Buy
22,025,323
+2,050,323
+10% +$233M 0.72% 38
2016
Q1
$2.16B Sell
19,975,000
-1,975,000
-9% -$204M 0.6% 47
2015
Q4
$2.25B Hold
21,950,000
0.63% 40
2015
Q3
$2.05B Hold
21,950,000
0.6% 44
2015
Q2
$2.14B Sell
21,950,000
-1,895,000
-8% -$190M 0.58% 46
2015
Q1
$2.4B Buy
23,845,000
+200,000
+0.8% +$20.3M 0.65% 43
2014
Q4
$2.47B Sell
23,645,000
-3,910,000
-14% -$412M 0.67% 44
2014
Q3
$2.94B Sell
27,555,000
-3,905,000
-12% -$405M 0.83% 30
2014
Q2
$3.29B Sell
31,460,000
-800,000
-2% -$80.9M 0.91% 26
2014
Q1
$3.17B Buy
32,260,000
+4,460,000
+16% +$413M 0.9% 25
2013
Q4
$2.55B Buy
27,800,000
+1,100,000
+4% +$101M 0.72% 36
2013
Q3
$2.31B Buy
26,700,000
+1,000,000
+4% +$89.7M 0.7% 37
2013
Q2
$2.21B Buy
+25,700,000
New +$2.18B 0.72% 34

Other funds holding JNJ

Capital World Investors's JNJ Position: Q1 2026 in Review

Capital World Investors increased its Johnson & Johnson (JNJ) stake by 21% in Q1 2026, buying an estimated $479M and bringing the position to 11,749,361 shares worth $2.87B. The position accounts for 0.39% of the portfolio, ranked #69.

Capital World Investors first reported a position in JNJ in Q2 2013 and has held it in 44 quarters since. The position peaked at $3.68B in Q4 2020. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Capital World Investors held 11,749,361 shares of Johnson & Johnson worth $2.87B as of Q1 2026.
  • Capital World Investors bought 2,056,477 Johnson & Johnson shares in Q1 2026, an estimated $479M.
  • Johnson & Johnson made up 0.39% of Capital World Investors's portfolio in Q1 2026, its #69 holding.
  • Capital World Investors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 44 quarters since.
  • Capital World Investors's Johnson & Johnson position peaked at $3.68B in Q4 2020.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Capital World Investors's 13F filing for Q1 2026, filed 13 May 2026.